Multicenter randomized Phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolization (TLC) for unresectable hepatocellular carcinoma (HCC) in cirrhotic patients. - Doffoel,M.; Vetter,D.; Bouche,O. (Proc ASCO, 2005)